FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

126093005: Dydrogesterone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
8241014 Dydrogesterone en Synonym Active Entire term case insensitive SNOMED CT core module
730011015 Dydrogesterone (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dydrogesterone Is a Progesterone false Inferred relationship Existential restriction modifier
Dydrogesterone Is a Synthetic steroid false Inferred relationship Existential restriction modifier
Dydrogesterone Is a Synthetic progestogen true Inferred relationship Existential restriction modifier
Dydrogesterone Is a Pregnane true Inferred relationship Existential restriction modifier
Dydrogesterone Is a Progesterone derivative false Inferred relationship Existential restriction modifier
Dydrogesterone Has disposition Progestational hormone false Inferred relationship Existential restriction modifier
Dydrogesterone Is a Steroid hormone true Inferred relationship Existential restriction modifier
Dydrogesterone Is a Progestational hormone false Inferred relationship Existential restriction modifier
Dydrogesterone Has disposition Progesterone receptor agonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dydrogesterone 10mg / Estradiol 2mg tablets (Lexon (UK) Ltd) 42 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd) 84 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg / Estradiol 2mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg / Estradiol 2mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Mawdsley-Brooks & Company Ltd) 84 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg / Estradiol 2mg tablets (Mawdsley-Brooks & Company Ltd) 42 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Stephar (U.K.) Ltd) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Stephar (U.K.) Ltd) 84 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 1mg/5mg tablets (Doncaster Pharmaceuticals Ltd) 84 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 2mg / Dydrogesterone 10mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 2mg / Dydrogesterone 10mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 2mg / Dydrogesterone 10mg tablets (Doncaster Pharmaceuticals Ltd) 42 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets (Special Order) Has active ingredient False Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets (Special Order) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets 1 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Dydrogesterone 10mg tablets (Special Order) 1 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 2mg / Dydrogesterone 10mg tablets (Waymade Healthcare Plc) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 2mg / Dydrogesterone 10mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 2mg / Dydrogesterone 10mg tablets (Waymade Healthcare Plc) 42 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 500micrograms / Dydrogesterone 2.5mg tablets Has active ingredient False Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 500micrograms / Dydrogesterone 2.5mg tablets Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Estradiol 500micrograms / Dydrogesterone 2.5mg tablets 84 tablet Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier
Femoston-conti 0.5mg/2.5mg tablets (Viatris UK Healthcare Ltd) 84 tablet 3 x 28 tablets Has specific active ingredient True Dydrogesterone Inferred relationship Existential restriction modifier

Start Page 2 of 2

This concept is not in any reference sets

Back to Start